SynbiCITE welcomes RebelBio to London
- Posted on 6 December, 2017
We're the world's first early stage life sciences accelerator. Twice a year we invest up to $250K in startups solving global challenges with life itself. We run a crucible that transforms scientists into entrepreneurs.
On top of our cash investment, during the program, teams have access to a fully equipped biosafety level lab, co-working space, dedicated mentorship and the support of a network of RebelBio alumni, investors, corporates and press partners.
RebelBio is an SOSV Accelerator.
Apply here: https://goo.gl/iencnF
Share this article:
People also read
Save the date for our first Synthetic Biology Industrial Translation Showcase
The inaugural SynbiCITE – Synthetic Biology Industrial Translation Showcase will take place on Tuesday 5th June from 9.00am-5.00pm at the Royal Academy of Engineering
Prokarium secures $10 million investment
Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccinesKeele...
Transformational European Commission Grant dramatically accelerates novel biomaterial company Customem
CustoMem, founded in 2015 by two Imperial College London graduates, Henrik Hagemann and Gabi Santosa, has received a substantial €1.4m grant that will...